Morning Watch List: Gilead Sciences Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Planar Systems Inc. (NASDAQ:PLNR), Grupo Financiero Santander Mexico (NYSE:BSMX), ULTA

Merck & Co. won’t move forward with an ultra-short hepatitis C regimen that attempted to cut treatment durations in half by combining two of its drugs with another from Gilead Sciences Inc. (NASDAQ:GILD). Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 45.40% and weekly performance is -4.96%. On last trading day company shares ended up $106.45. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is 0.18%.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the presentation of results from the ongoing Phase 2 study of ACH-3102 in a late breaker poster and data in three preclinical posters on ACH-3422. The poster presentations are being made at the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), The Liver Meeting 2014, which takes place through November 11, 2014 in Boston, MA. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares moved down -1.46% in last trading session and ended the day at $10.11. ACHN return on assets is -38.00%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) quarterly performance is 33.20%.

Planar Systems, Inc. (NASDAQ: PLNR), reported financial results for the fiscal fourth quarter and year ended September 26, 2014. Total revenue increased 17% year on year to $53.6 million compared to the fourth quarter of fiscal 2013. Revenue was driven by a 42% increase in sales of DS products, which totaled $25.2 million in the fourth fiscal quarter of 2014, compared to $17.7 million in the same period a year ago. On 07 November, Planar Systems Inc. (NASDAQ:PLNR) shares increased 0.16% and was closed at $6.40. PLNR EPS growth in last 5 year was 44.60%. Planar Systems Inc. (NASDAQ:PLNR) year to date (YTD) performance is 151.97%.

On Nov. 4, Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) announced financial results for the three-month and nine-month periods ending September 30, 2014. Reported net income for the quarter was Ps.3,244 million, representing declines of 44.8% YoY and 12.0% QoQ. Comparable 3Q13 results exclude an extraordinary net non-cash benefit of Ps.2,803 million before taxes related to a mandatory regulatory change in employee profit sharing (EPS) future payments. Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) ended the last trading day at $11.86. Company weekly volatility is calculated as 3.46% and price to cash ratio as 0.65. Grupo Financiero Santander Mexico, S.A.B. de C.V. (NYSE:BSMX) showed a weekly performance of -10.83%.

Ulta Salon, Cosmetics & Fragrance (NASDAQ:ULTA) has earned an average rating of “Hold” from the twelve ratings firms that are currently covering the stock, Analyst Ratings News reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. ULTA Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) shares moved down -0.27% in last trading session and ended the day at $121.75. ULTA Gross Margin is 35.10% and its return on assets is 13.70%. ULTA Salon, Cosmetics & Fragrance, Inc. (NASDAQ:ULTA) quarterly performance is 27.77%.